Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma

BACKGROUND: To overcome challenges with traditional response assessment in anti-angiogenic agents, the current study uses T1 subtraction maps to quantify volumetric radiographic response in monotherapy with cabozantinib, an orally bioavailable tyrosine kinase inhibitor with activity against vascular...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Ellingson, Benjamin M, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Chakhoyan, Ararat, Raymond, Catalina, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Wen, Patrick Y, Cloughesy, Timothy F
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Neuroimaging
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120362/
https://ncbi.nlm.nih.gov/pubmed/29660005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy054
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker